Table of Contents Chapter 1 Introduction Study Goals and Objectives Reasons for Doing This Study Scope of the Report Methodology Information Sources Geographic Breakdown Segmentation Breakdown Chapter 2 Summary and Highlights Market Outlook Market Summary Chapter 3 Market and Technology Background Introduction Types of Biomarkers Future Outlook Chapter 4 Market Dynamics Market Dynamics Snapshot Market Drivers Unmet Needs in Cancer Screening Government Measures for Cancer Screening Market Restraints Risk of False Positives or False Negatives Regulatory and Reimbursement Uncertainty Chapter 5 Market Breakdown by Test Type Global Multi-Cancer Diagnostic Test Market, by Test Type Market Size and Forecast Laboratory Developed Tests In-Vitro Diagnostic Tests Chapter 6 Market Breakdown by End User Global Multi-Cancer Diagnostic Test Market, by End User Hospitals Diagnostic Laboratories Research Institutions Chapter 7 Market Breakdown by Region Global Multi-Cancer Diagnostic Test Market, by Region The U.S. Europe Emerging Markets Chapter 8 Emerging Technologies Introduction Identification of Tissue of Origin Fragmentomics and Tumor-Educated Platelets Liquid Biopsy with Imaging Data Analysis Chapter 9 Competitive Landscape Porter's Five Forces Analysis Threat of New Entrants Threat of Substitutes Bargaining Power of Suppliers Bargaining Power of Buyers Degree of Competition Recent Developments in the Multi-Cancer Diagnostic Market Clinical Trial Activities Chapter 10 Company Profiles ANCHORDX MEDICAL CO. LTD. BURNING ROCK BIOTECH LTD. DELFI DIAGNOSTICS EXACT SCIENCES CORP. FREENOME HOLDINGS INC. GENECAST INC. GRAIL INC. GUARDANT HEALTH INC.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook